DNAPrint Genomics(OTC) DNAG

Market Cap$1.30K

Since IPO (1990)-100%

5 Year-99%

1 Year+0%

1 Month+0%

$0.00

+0.00%

+0.00Today

DNAPrint Genomics last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-07-02

DNAPrint Genomics stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-06-15
1 month	+0%	USD 0.00	2026-05-21
3 month	+0%	USD 0.00	2026-03-25
Year to date	+0%	USD 0.00	2025-12-30
1 year	+0%	USD 0.00	2025-06-12
3 year	+0%	USD 0.00	2023-06-30
5 year	-99%	USD 0.00	2021-06-25
Since inception	-100%	USD 0.20	1990-08-21

DNAPrint Genomics Financials at a Glance

Market Cap

$1.30K

Revenue (TTM)

$1.93M

Net Income (TTM)

-$4.55M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

10.88 (High)

Dividend

$0.00

Beta (Volatility)

10.88 (High)

Price

$0.00

Volume

500

Open

$0.00

Price

$0.00

Volume

500

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Nov 18, 2024

Dividend

$0.00

Beta (Volatility)

10.88 (High)

Price

$0.00

Volume

500

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Nov 18, 2024

DNAG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About DNAPrint Genomics

DNAPrint Genomics, Inc. is a biotechnology company specializing in genetic analysis solutions and services. The company offers a diverse range of products aimed at ancestry tracing, forensic science, and pharmaceutical research.

Products and Services

AncestryByDNA: A chromosomal assay for tracing genetic lineage
DNAWitness: A forensic tool for determining genetic background from crime scene samples
GenomeLab SNPstream: A high-throughput genotyping system recognized for efficiency

Growth Outlook

Expansion into forensic science and genealogical exploration markets is underway
Increasing demand for genetic analysis solutions supports potential revenue growth
Strategic partnerships may enhance product offerings and market reach

Financial Highlights

Recent quarterly revenue of 227,562 reflects ongoing operational challenges
Trailing twelve months (TTM) gross profit margin stands at 30.99%
Current ratio of 0.64 indicates potential liquidity concerns

DNAPrint Genomics, Inc. operates in a rapidly evolving biotechnology sector, focusing on innovative genetic analysis solutions. The company's product offerings cater to various markets, including ancestry, forensic science, and pharmaceutical research. Despite facing operational challenges, the company is positioned to capitalize on the growing demand for genetic analysis services. The recent quarterly revenue indicates ongoing efforts to stabilize operations, while the gross profit margin suggests potential for profitability in the future. However, the current ratio highlights liquidity concerns that may need addressing. Overall, DNAPrint Genomics presents an intriguing opportunity for investors interested in the biotechnology field.

AI Generated • Jul 18, 2026

Industry

Biotechnology

Sector

Health Care

Headquarters

Sarasota, FL 34243, US

DNAG Financials

Key Financial Metrics (TTM)

Gross Margin

30.99%

Operating Margin

-364.45%

Net Income Margin

-507.54%

Return on Equity

316.59%

Return on Capital

-248.20%

Return on Assets

-120.24%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.30K

Shares Outstanding

1.29B

Volume

500

Avg. Volume

46.10K

Financials (TTM)

Gross Profit

$446.37K

Operating Income

$6.31M

EBITDA

-$5.09M

Operating Cash Flow

-$4.14M

Capital Expenditure

-$165.00K

Free Cash Flow

-$4.31M

Cash & ST Invst.

$134.35K

Total Debt

$5.33M

DNAPrint Genomics Performance Analysis

DNAPrint Genomics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2006-12-31	-19.3%
Q1	2007-03-31	33.4%
Q2	2007-06-30	-32.0%
Q3	2007-09-30	-52.3%

DNAPrint Genomics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2006-12-31	10.0%
Q1	2007-03-31	211.1%
Q2	2007-06-30	-130.0%
Q3	2007-09-30	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2007YOY CHG

Revenue

$227.56K

-65.1%

Gross Profit

-$6.59K

-103.0%

Gross Margin

-2.90%

N/A

Market Cap

$1.30K

N/A

Market Cap/Employee

$54.17

N/A

Employees

N/A

Net Income

-$1.88M

+43.7%

EBITDA

-$1.51M

+31.8%

Quarterly Fundamentals

Name

Q3 2007YOY CHG

Total Cash

$134.35K

+21.3%

Total Debt

$5.33M

-21.0%

Accounts Receivable

$1.43M

+583.8%

Inventory

$289.16K

+47.6%

Long Term Debt

$259.54K

-40.2%

Short Term Debt

$5.07M

-19.7%

Return on Assets

-1.20%

N/A

Return on Invested Capital

2.53%

N/A

Free Cash Flow

-$1.36M

-2.6%

Operating Cash Flow

-$1.36M

-9.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IPAHInterpharm Holdings, Inc.

IPAHInterpharm Holdings, Inc.$0.00+0.00%

LADXLadRx Corporation

LADXLadRx Corporation$0.01-89.72%

AVXTAVAX Technologies, Inc.

AVXTAVAX Technologies, Inc.$0.00+0.00%

MHTXManhattan Scientifics, Inc.

MHTXManhattan Scientifics, Inc.$0.00+0.00%

BRAXFBraxia Scientific Corp.

BRAXFBraxia Scientific Corp.$0.00+0.00%

MRPIMera Pharmaceuticals, Inc.

MRPIMera Pharmaceuticals, Inc.$0.00+0.00%

USRMU.S. Stem Cell, Inc.

USRMU.S. Stem Cell, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PLTRPalantir Technologies

PLTRPalantir Technologies$162.66+0.29%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$125.33+0.09%

NVDANvidia

NVDANvidia$211.94+0.03%

INTCIntel

INTCIntel$100.86+0.11%

AMIXAutonomix Medical

AMIXAutonomix Medical$19.50+4.34%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$8.07+0.03%

NOKNokia

NOKNokia$9.92+0.06%

Questions About DNAG

What is the current price of DNAPrint Genomics?

DNAPrint Genomics is trading at $0.00 per share.

What is the 52-week range for DNAPrint Genomics?

Over the past 52 weeks, DNAPrint Genomics has traded between $0.00 and $0.00.

How much debt does DNAPrint Genomics have?

DNAPrint Genomics total debt is unavailable.

How much cash does DNAPrint Genomics have on hand?

DNAPrint Genomics does not have cash on hand data available.

What is DNAPrint Genomics’s dividend yield?

DNAPrint Genomics does not currently have a dividend yield.

DNAPrint Genomics(OTC) DNAG

DNAPrint Genomics Financials at a Glance

DNAG News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About DNAPrint Genomics

DNAG Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

DNAPrint Genomics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About DNAG

What is the current price of DNAPrint Genomics?

What is the 52-week range for DNAPrint Genomics?

How much debt does DNAPrint Genomics have?

How much cash does DNAPrint Genomics have on hand?

What is DNAPrint Genomics’s dividend yield?

Premium Investing Services